NAV | $31.99 | Daily Change | -$0.43 | -1.33% |
Market Price | $32.01 | Daily Change | -$0.53 | -1.63% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2022
Inception Date | 05/09/16 |
Total Expense Ratio | 0.50% |
Net Assets | $62.07 million |
NAV | $31.99 |
Fact Sheet | View the document |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Ticker | AGNG |
Bloomberg Index Ticker | ILNGRNT |
CUSIP | 37954Y772 |
ISIN | US37954Y7720 |
Primary Exchange | Nasdaq |
Shares Outstanding | 1,940,000 |
Number of Holdings | 83 |
30-Day Median Bid-Ask Spread | 0.37% |
30-Day SEC Yield | 0.95% |
Distribution Frequency | Semi-Annually |
NAV | $31.99 | Daily Change | -$0.43 | -1.33% |
Market Price | $32.01 | Daily Change | -$0.53 | -1.63% |
As of recent (09/30/24)
As of recent (09/30/24)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | 26.40% | 27.20% | 26.83% |
3 Years | 4.73% | 5.07% | 5.01% |
5 Years | 9.83% | 9.72% | 10.10% |
Since Inception | 10.37% | 10.67% | 10.66% |
1 Year | 29.26% | 29.44% | 29.78% |
3 Years | 3.48% | 3.48% | 3.76% |
5 Years | 8.10% | 8.03% | 8.38% |
Since Inception | 9.95% | 10.23% | 10.25% |
Year-to-Date | 15.27% | 15.84% | 15.54% |
1 Month | -1.21% | -1.03% | -1.16% |
3 Months | 8.95% | 9.14% | 9.11% |
Since Inception | 128.99% | 134.39% | 134.20% |
Year-to-Date | 12.59% | 12.94% | 12.93% |
1 Month | -2.32% | -2.50% | -2.26% |
3 Months | 2.96% | 2.93% | 3.10% |
Since Inception | 123.68% | 128.54% | 128.91% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
4.12 | WELL | WELLTOWER INC | BYVYHH4 | 134.88 | 18,936 | 2,554,087.68 |
3.89 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 48.19 | 50,049 | 2,411,683.31 |
3.37 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 84.02 | 24,856 | 2,088,401.12 |
3.36 | ABBV | ABBVIE INC | B92SR70 | 203.87 | 10,214 | 2,082,328.18 |
3.27 | AMGN | AMGEN INC | 2023607 | 320.16 | 6,337 | 2,028,853.92 |
3.13 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 55.77 | 34,833 | 1,942,636.41 |
3.12 | UCB BB | UCB SA | 5596991 | 191.94 | 10,075 | 1,933,818.98 |
3.09 | ALC SW | ALCON INC | BJT1GR5 | 92.03 | 20,840 | 1,917,945.18 |
3.01 | LLY | ELI LILLY & CO | 2516152 | 829.74 | 2,253 | 1,869,404.22 |
3.01 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 339.08 | 5,509 | 1,867,975.95 |
2.99 | MDT | MEDTRONIC PLC | BTN1Y11 | 89.25 | 20,823 | 1,858,452.75 |
2.96 | JNJ | JOHNSON & JOHNSON | 2475833 | 159.86 | 11,499 | 1,838,230.14 |
2.84 | SYK | STRYKER CORP | 2853688 | 356.28 | 4,941 | 1,760,379.48 |
2.82 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 71.15 | 24,637 | 1,752,922.55 |
2.51 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 838.20 | 1,859 | 1,558,213.80 |
2.45 | NOVOB DC | NOVO NORDISK A/S-B | BP6KMJ1 | 111.08 | 13,712 | 1,523,100.93 |
2.40 | 4543 JP | TERUMO CORP | 6885074 | 19.33 | 77,093 | 1,490,236.92 |
2.39 | 068270 KS | CELLTRION INC | B0C5YV1 | 132.25 | 11,224 | 1,484,333.33 |
2.19 | VTR | VENTAS INC | 2927925 | 65.49 | 20,767 | 1,360,030.83 |
2.02 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 67.01 | 18,686 | 1,252,148.86 |
1.82 | ZBH | ZIMMER BIOMET HO | 2783815 | 106.92 | 10,581 | 1,131,320.52 |
1.81 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 364.52 | 3,078 | 1,121,990.98 |
1.78 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 11.79 | 93,490 | 1,101,994.39 |
1.75 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 131.84 | 8,218 | 1,083,441.66 |
1.63 | SDZ SW | SANDOZ GROUP AG | BLPLD38 | 45.51 | 22,230 | 1,011,623.11 |
1.61 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 202.64 | 4,941 | 1,001,244.24 |
1.46 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 373.97 | 2,427 | 907,625.19 |
1.39 | DXCM | DEXCOM INC | B0796X4 | 70.48 | 12,228 | 861,829.44 |
1.38 | INCY | INCYTE CORP | 2471950 | 74.12 | 11,578 | 858,161.36 |
1.35 | PODD | INSULET CORP | B1XGNW4 | 231.53 | 3,612 | 836,286.36 |
1.23 | GMAB DC | GENMAB A/S | 4595739 | 223.36 | 3,413 | 762,341.57 |
1.15 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.33 | 306,643 | 715,489.82 |
1.04 | EXAS | EXACT SCIENCES CORP | 2719951 | 68.93 | 9,372 | 646,011.96 |
1.02 | DVA | DAVITA INC | 2898087 | 139.81 | 4,522 | 632,220.82 |
1.01 | COH AU | COCHLEAR LTD | 6211798 | 185.51 | 3,379 | 626,834.25 |
0.99 | NBIX | NEUROCRINE BIOSC | 2623911 | 120.27 | 5,129 | 616,864.83 |
0.95 | FME GR | FRESENIUS MEDICAL CARE AG | 5129074 | 38.99 | 15,158 | 590,943.30 |
0.90 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 12.36 | 45,171 | 558,089.67 |
0.87 | OHI | OMEGA HEALTHCARE | 2043274 | 42.47 | 12,658 | 537,585.26 |
0.83 | EXEL | EXELIXIS INC | 2576941 | 33.20 | 15,584 | 517,388.80 |
0.79 | TFX | TELEFLEX INC | 2881407 | 201.06 | 2,426 | 487,771.56 |
0.73 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 154.99 | 2,912 | 451,330.88 |
0.71 | PHM SM | PHARMA MAR SA | BMW2GT8 | 76.59 | 5,746 | 440,099.77 |
0.68 | DEMANT DC | DEMANT A/S | BZ01RF1 | 36.62 | 11,536 | 422,485.99 |
0.54 | GKOS | GLAUKOS CORP | BYMWL19 | 132.25 | 2,543 | 336,311.75 |
0.53 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 50.57 | 6,535 | 330,474.95 |
0.52 | AMP IM | AMPLIFON SPA | B14NJ71 | 27.90 | 11,660 | 325,327.05 |
0.50 | YPSN SW | YPSOMED HOLDING AG-REG | B02SWN8 | 443.51 | 703 | 311,785.01 |
0.47 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 98.66 | 2,981 | 294,105.46 |
0.45 | MNKD | MANNKIND CORP | BF081J4 | 7.07 | 39,575 | 279,795.25 |
0.44 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 87.51 | 3,149 | 275,568.99 |
0.40 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 44.43 | 5,559 | 246,986.37 |
0.39 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 19.40 | 12,344 | 239,473.60 |
0.37 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 25.96 | 8,880 | 230,524.80 |
0.36 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 76.65 | 2,889 | 221,441.85 |
0.35 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 116.03 | 1,895 | 219,876.85 |
0.35 | EMBC | EMBECTA CORP | BMXWYR1 | 14.08 | 15,456 | 217,620.48 |
0.35 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 12.35 | 17,539 | 216,666.01 |
0.35 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 124.25 | 1,721 | 213,834.25 |
0.34 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 11.23 | 18,561 | 208,385.99 |
0.33 | LTC | LTC PROPERTIES INC | 2498788 | 38.20 | 5,290 | 202,078.00 |
0.31 | 8086 JP | NIPRO CORP | 6641599 | 9.27 | 20,649 | 191,476.86 |
0.30 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 2.96 | 63,184 | 186,891.52 |
0.30 | NVCR | NOVOCURE LTD | BYSS4X4 | 15.18 | 12,048 | 182,888.64 |
0.29 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 0.83 | 219,602 | 181,909.46 |
0.28 | AED BB | AEDIFICA | B1G5XP1 | 64.11 | 2,731 | 175,077.41 |
0.28 | AMED | AMEDISYS INC | 2024332 | 94.60 | 1,844 | 174,442.40 |
0.27 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.36 | 472,624 | 169,610.64 |
0.26 | LIVN | LIVANOVA PLC | BYMT0J1 | 51.62 | 3,144 | 162,293.28 |
0.26 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.21 | 746,392 | 160,330.65 |
0.26 | BKD | BROOKDALE SR | B0PZN33 | 6.27 | 25,533 | 160,091.91 |
0.25 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 8.24 | 19,038 | 156,873.12 |
0.25 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 0.62 | 248,389 | 153,038.60 |
0.24 | GN DC | GN STORE NORD A/S | 4501093 | 19.41 | 7,771 | 150,839.94 |
0.23 | ACAD | ACADIA PHARMACEU | 2713317 | 14.59 | 9,776 | 142,631.84 |
0.23 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 5.99 | 23,276 | 139,437.82 |
0.22 | ALEC | ALECTOR INC | BJ4LDC4 | 4.92 | 27,243 | 134,035.56 |
0.21 | OTHER PAYABLE & RECEIVABLES | 1.00 | 131,603 | 131,603.26 | ||
0.21 | 9229 JP | SUNWELS CO LTD | BNTYNB5 | 11.97 | 10,679 | 127,874.58 |
0.17 | 145720 KS | DENTIUM CO LTD | BF07GJ6 | 57.03 | 1,801 | 102,709.20 |
0.15 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 7.85 | 12,139 | 95,291.15 |
0.13 | AGL | AGILON HEALTH INC | BLR4TK4 | 2.55 | 31,921 | 81,398.55 |
0.08 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 0.47 | 102,940 | 48,368.98 |
0.00 | RADIUS HEALTH INC - CVR | 2KFF9T0 | 0.00 | 19,104 | 0.02 | |
0.00 | CANADIAN DOLLAR | 1.00 | 0 | -0.01 | ||
0.00 | DANISH KRONE | 0.15 | -308 | -44.84 | ||
0.00 | SWISS FRANC | 1.16 | -1,261 | -1,458.68 | ||
0.00 | CASH | 1.00 | -2,207 | -2,206.66 | ||
-0.01 | EURO | 1.09 | -2,869 | -3,114.69 |
Sector | Weight (%) | |
---|---|---|
Health Care | 92.0 | |
Real Estate | 8.1 |
Industry | Weight (%) | |
---|---|---|
Pharmaceuticals, Biotechnology & Life Sciences | 48.3 | |
Health Care Equipment & Services | 39.2 | |
Equity Real Estate Investment Trusts (REITs) | 8.1 | |
Pharmaceuticals, Biotechnology | 4.4 |
Country | Weight (%) | |
---|---|---|
United States | 52.2 | |
Switzerland | 12.0 | |
Japan | 8.2 | |
Denmark | 4.8 | |
Britain | 4.8 | |
China | 4.6 | |
Belgium | 3.2 | |
Ireland | 2.9 | |
South Korea | 2.7 | |
Australia | 1.1 | |
Germany | 1.0 | |
Other | 2.5 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.